Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.
Journal: Advances in therapy
Published: March 09, 2026
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities.
Journal: Annals of hepatology
Published: October 23, 2025
Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design.
Journal: JACC. Advances
Published: September 19, 2025
Fat, muscle, and anti-obesity medications in cardiovascular disease prevention.
Journal: European heart journal
Published: September 16, 2025
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial.
Journal: Diabetes care
Published: April 22, 2025
Use of finerenone in patients with chronic kidney disease at high risk of heart failure.
Journal: Metabolism: clinical and experimental
Published: February 11, 2025
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States.
Journal: Hepatology communications
Published: January 30, 2025
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.
Journal: Diabetes care
Published: December 20, 2024
Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic disease.
Journal: The American journal of managed care
Published: December 20, 2024
Last Updated: 09/26/2026